ACT for NIH Announces New Advisory Comittee Members
With health threats spreading over a more highly-connected world, the National Institutes of Health must be better funded, writes guest columnist Alan Aderem.
As the Ebola epidemic continues to grow and drug companies scramble to test vaccines, one of the top U.S. health officials warned that outbreaks like Ebola will happen again.
The National Institute of Allergy and Infectious Diseases – where most Ebola research is funded – saw its budget cut to $4.4 billion last year, down from $4.5 billion in 2010.
The National Institutes of Health (NIH), led by its National Institute of Allergy and Infectious Diseases (NIAID), is spearheading efforts to develop treatments and a vaccine for Ebola as quickly as possible.
The first case of Ebola has been diagnosed in the U.S. While this was anticipated and experts like Dr. Anthony Fauci, the head of the National Institute of Allergy and Infectious Diseases, assure us it will not lead to an outbreak here, it is concerning.
ACT for NIH: Advancing Cures Today announced a national, non-partisan effort to seek an immediate, significant funding increase for the National Institutes of Health (NIH) to enhance life-saving medical research for patients around the world.
President Obama said Sunday that the U.S. military will begin aiding what has been a chaotic and ineffective response to the Ebola epidemic in West Africa, arguing that it represents a serious national security concern.
Initial human testing of an investigational vaccine to prevent Ebola virus disease will begin next week by the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health.
As the outbreak of Ebola Virus Disease continues to spread in West Africa, now affecting four countries in the region, I am reminded how fragile life is—and how important NIH’s role is in protecting it. NIH research has helped us understand how Ebola initially infects people and how it spreads from person to person.